Recent Press Releases

Amgen to terminate participation in co-development and commercialization of brodalumab

THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has

Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab) For The Treatment Of High Cholesterol

First Positive Regulatory Agency Determination for a PCSK9 Inhibitor

THOUSAND OAKS, Calif., May 22, 2015

New treatment option recommended for patients with advanced melanoma

Keytruda extends range of treatment options for melanoma patients with poor prognosis The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Keytruda...

New treatment option for patients with advanced lung cancer

Recommendation of Nivolumab BMS follows previous positive opinion for nivolumab to treat advanced melanoma The European Medicines Agency (EMA) has recommended granting a marketing...

PuriCore Release: Announces The Appointment Of Alex Martin As CEO Life Sciences Executive To Drive Future Strategy

19 May 2015 – PuriCore plc (AIM: PURI), an international company focused on safe and effective protection against the spread of infectious pathogens, today announces that Alex Martin will be...

Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab) For The Treatment Of High Cholesterol

First Positive Regulatory Agency Determination for a PCSK9 Inhibitor  THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (AMGN) today announced that the Committee for Medicinal Products...

CVS Health and Omnicare Sign Definitive Agreement for CVS Health to Acquire Omnicare

WOONSOCKET, R.I.and CINCINNATI, May 21, 2015 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) and Omnicare, Inc. (NYSE:OCR) announced today that they have entered into a definitive agreement for CVS...

Divestment of portfolio of branded and generic products to Strides entities

Divestment of portfolio of branded and generic products to Strides entities 21/05/15: Shauneen Beukes Aspen is pleased to announce that certain of its wholly owned Australian subsidiaries...

Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen

Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen Breakthrough Designation for daclatasvir and sofosbuvir...

Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue

Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue...

New Study Shows Inner-City Asthma Care Program Reduces Student Absenteeism by up to 20 Percent

RESEARCH TRIANGLE PARK, N.C., May 19, 2015 /PRNewswire/ -- New data from a school asthma management prog

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

- More Than 100,000 People with Coronary Artery Disease Have Been Treated with Absorb

PARIS, May 19, 2015

ASTELLAS AND MEDIVATION ANNOUNCE NEW ENZALUTAMIDE DATA PRESENTED AT THE 2015 AMERICAN UROLOGY ASSOCIATION ANNUAL MEETING

TOKYO and SAN FRANCISCO – May 17, 2015 – Astellas Pharma Inc (TSE:4503) and Medivation, Inc (NASDAQ: MDVN) today announced data from the Phase 2 STRIVE trial comparing enzalutamide and...

Baxter and Baxalta Highlight Business Strategies at Investor Conferences

Companies Outline Vision for Accelerated and Sustainable Growth, Showcase InnovationSeparation into Two Independent Companies On-Track for Mid-Year 2015 DEERFIELD, Ill., May 18, 2015 (BUSINESS...

New US poll shows most parents (83%) want their teens and young adults to be vaccinated against meningococcal disease

Less than half of parents say they have talked to their child about how the disease is spread or its early symptoms - In 2015, meningococcal disease cases have been reported on college campuses...

Merck Starts a Challenging 2015 with a Solid First Quarter

Integration of AZ Electronic Materials, favorable currency environment and organic business drive overall net sales growth of 15.7% • Organic sales growth of 1.3% • EBITDA pre exceptionals...

Amgen Appoints Jonathan P. Graham Senior Vice President, General Counsel And Secretary

THOUSAND OAKS, Calif., May 18, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of <

Blue Cross Withholds Cure from Hepatitis C Patients, Lawsuit Claims

LOS ANGELES, May 15, 2015 /PRNewswire/ -- Shernoff Bidart Echeverria Bentley LLP filed a lawsuit in Los Angeles Superior Court today accusing Blue Cross of withholding a cure for Hepatitis C based...